CStone Pharmaceuticals (CStone Pharmaceuticals) Total Equity : $0.00 Mil (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is CStone Pharmaceuticals Total Equity?

CStone Pharmaceuticals's total equity for the quarter that ended in Jun. 2023 was $0.00 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

CStone Pharmaceuticals Total Equity Historical Data

The historical data trend for CStone Pharmaceuticals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Total Equity Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

Get a 7-Day Free Trial

353.82

451.80

189.50

64.45

63.98

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Equity	Get a 7-Day Free Trial									189.50	141.98	64.45	-	63.98

CStone Pharmaceuticals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

CStone Pharmaceuticals's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	232.766	-	168.786
	=	63.98

CStone Pharmaceuticals's Total Equity for the quarter that ended in Jun. 2023 is calculated as

Total Equity	=	Total Assets(Q: Jun. 2023 )	-	Total Liabilities(Q: Jun. 2023 )
	=	N/A	-	N/A
	=	N/A

CStone Pharmaceuticals Total Equity Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals (CStone Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (OTCPK:CSPHF) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

02616:Hong Kong PH4:Germany

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.